Tag: Upstart

21 December 2020 – ByteDance Raising $2bn at $180bn Valuation

Podcast: Play in new window | Download

Subscribe: RSS

The Big Ones

Ant Group may not have been able to successfully go public but China’s other hugely valuable VC-backed private company, ByteDance, is reportedly in the process of raising $2bn at a $180bn valuation. KKR and Sequoia Capital are co-leading the round, but no word yet on whether it’s set to include SoftBank, a participant in its last round, in 2018, which valued it at $78bn.

Luxembourg-headquartered venture capital fund European Circular Bioeconomy Fund (ECBF) reached a €175m ($213m) second close on Tuesday with €93m from limited partners including corporates Volkswohl Bund Versicherungen, Nestlé and Neste. Insurance provider Volkswohl Bund Versicherungen, packaged food and beverage producer Nestlé and oil processor Neste were joined in the second close by promotional bank NRW Bank and an unnamed family office. ECBF was launched by the European Commission and European Investment Bank in November 2019. The European Investment Bank has provided a total of €100m for the vehicle as a cornerstone investor. The fund is focused on late-stage investments in bioeconomy technology developers located in Europe. It is two thirds of the way towards a targeted close of €250m.

Roblox and Affirm may be putting their initial public offerings back to 2021, but that hasn’t stopped mobile commerce platform developer Wish pricing an IPO that will net it just over $1.1bn. The JD.com-backed company is floating at the top of its range after pumping its revenue up 32% in the first nine months of 2020, at a valuation about 50% higher than in its last round, in August 2019, so the outcome of this one is going to be very interesting. Were the others priced badly or is the market just supercharged right now?

University of British Columbia-linked AbCellera was one of the recent IPO candidates that saw a huge first-day pop, pricing an upsized $483m IPO at $20 per share early in the week only for its shares to open at more than three times that price. The Eli Lilly-backed antibody therapy developer eventually closed that offering at $556m after the underwriters unsurprisingly took up the over-allotment option. It won’t be the last time that happens this year.

Deals

Google X may not have been the goldmine some at its parent company hoped for, but an unqualified success at this point has to be Verily, the company applying big data technology to healthcare and life sciences. Verily has just raised $700m from existing investors including Google owner Alphabet, representing its third mega round in total. Alphabet was joined by Temasek, which invested $800m in Verily in 2017, as well as Silver Lake and Ontario Teachers’ Pension Plan, which had added $1bn two years later.

Xingsheng Preference Electronic Business, the group buying platform mainly known as Xingsheng Youxuan, has agreed to raise $700m from e-commerce group JD.com through a strategic collaboration agreement. The news was revealed in a regulatory filing without a valuation attached, but Xingsheng Youxuan was reportedly in the process of securing $800m in a Tencent-backed round in July at a $4bn post-money valuation.

Apex Microelectronics, a chipmaker spinoff of printing and imaging technology producer Ninestar, has raised $489m from investors including Gree Electric Appliance’s Zhuhai Gree Financial Investment Management vehicle. The round was led by the $31bn China Integrated Circuit Industry Investment Fund II, and Gree Financial Investment Managementsupplied $53.5m in return for a 1.8% stake.

StockX runs an e-commerce marketplace that specialises in collectible and high-grade goods such as sneakers, handbags and electronics, and has raised $275m in series E funding at a $2.8bn post-money valuation. Tiger Global Management led the round, and StockX’s earlier investors include GV, the Alphabet subsidiary formerly known as Google Ventures, which has had some year it’s fair to say.

With vaccines beginning to be rolled out, it feels like the tech space is finally looking forward to a 2021 where some dormant sectors will be making big returns (potentially in both senses of the word). That could be part of the impetus behind the $182m in funding just raised by ride hailing service Bolt. Daimler and Didi Chuxing-backed Bolt has diversified its business model by leaning more heavily on logistics in recent months, and the round looks to have more than doubled its valuation to roughly $4.3bn.

Tencent has co-led a $153m funding round for Yonghui Fresh Food, a business-to-business fresh produce distribution subsidiary of supermarket chain Yonghui Superstore, with China International Capital Corporation’s CICC Qizhi fund. The round also featured Yonghui Superstore itself, which retains a 32% stake in the company having also backed its $145m series A round two years ago.

Funds

China-based venture capital firm BeFor Capital has amassed RMB700m ($107m) of capital across two funds, one backed by solar cell manufacturer Canadian Solar. The firm pulled in approximately $76.4m for the first close of its Fund III and $30.5m for the close of Fund IV. It now has over $306m of capital under management across four funds and a number of special purpose vehicles. Canadian Solar contributed to Befor Capital’s Fund III alongside funds backed by the government of China’s Inner Mongolia and Hohhot regions.

Exits

Boehringer Ingelheim has agreed to acquire one of its portfolio companies, oncology therapy developer NBE-Therapeutics, in a transaction that could reach $1.43bn once milestone payments are factored in. NBE is working on antibody-drug conjugates to treat cancer, and has raised approximately $68m from investors including Boehringer Ingelheim Venture Fund and pharmaceutical firm Novo.

Lidar sensor and software provider Innoviz has chosen the reverse merger route, one boosted by $200m in PIPE financing from investors including corporate backers Magna International and Phoenix Insurance. The combined company will be valued at about $1.4bn once the deal closes, and Innoviz’s existing investors also include Samsung Catalyst, SoftBank Ventures Asia, Naver, Delek Motors, Delphi Automotive and Harel Insurance Investments and Financial Services.

Upstart, the owner of an online lending platform that utilises artificial intelligence in its activities, is also valued above $2bn, following a $240m initial public offering. Its shares rocketed up 47% in their first day of trading yesterday and its pre-IPO backers include Rakuten, Progressive and GV, which sold $1.6m of shares having backed Upstart’s $1.75m seed round eight years ago. Its remaining stake is worth about $28m at the current share price.

The second half of 2020 has been a bonanza period for IPOs, and things don’t show any sign of slowing down either, not with the sky-high valuations companies are seeing as soon as they hit the market. UiPath, a provider of robotic process automation software, has filed confidentially to go public, five months after a Tencent-backed series E round valuing it at $10.2bn. It has so far raised some $1.3bn in funding, with Alphabet’s CapitalG also among its investors.

Coinbase is the other unicorn to have confidentially filed to go public in the last day or so, the crypto trading platform having been valued at $8bn in its last round two years ago. Now that figure looks sure to rise, given the increasing activity in blockchain technology and the recent shooting up of Bitcoin prices. It has raised approximately $517m from investors that include New York Stock Exchange, NTT Docomo, BBVA and USAA.

“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

09 November 2020 – Ant Group’s IPO Suspended by Regulators

Podcast: Play in new window | Download

Subscribe: RSS

The Big Ones

Law firm Orrick Herrington and Sutcliffe’s recent investments in Priori Legal and term sheet data analysis provider Aumni, coinciding with Latham & Watkins and Clifford Chance’s joint investment in legal tech platform Reynen Court’s recent $4.5m round, reflect the strategic interest in so-called legaltech startups.

The $30m Hypertherm Ventures fund is targeting early-stage deals in advanced manufacturing, which is a difficult place to back with limited capital and an awareness of the lengthy time horizons required.

As Car and Driver magazine noted, the electric vehicle market is challenged as few consumers are interested, they are expensive compared to petrol or diesel cars, and traditional car companies have struggled to develop appealing brands, leaving the way for Tesla and other startups out of China such as Nio to try and take advantage. But the future seems to lie in that direction given a predicted 21.1% compound annual growth rate over the next decade. As a result, Polestar, a Sino-Swedish electric car brand jointly owned by Volvo Car Group and its parent company Geely, is in talks to raise $500m from investors at a $6bn valuation, according to Bloomberg.

It is always fun as the end of year creeps up to think about the technologies that will disrupt or transform the world over the next few decades, and Adrien Book’s selectionbelow covers a number of general and specific purpose technologies. The meatless meat one is definitely catching people’s attention currently, given the post-flotation performance of Beyond Meat among others, as identified in March’s special report on agtech. The wider focus, however, is “how to replace the grocery store,” according to venture capitalists such as Andrew Ive, founder at Big Idea Ventures with Tom Mastrobuoni, former partner at meat supplier Tyson’s corporate venturing unit.

The European Union has more than halved its planned investment in the continent’s best entrepreneurs after budget cuts wiped at least €6bn ($6.8bn) off its European Innovation Council (EIC).Stéphane Ouaki, head of unit for the directorate general of research and innovation at the European Commission, in a panel at the Not Optional – Making Europe the Most Entrepreneurial Continent event on Friday, said the funding for the EIC would come in at €3.5-4bn for the seven-year Horizon Europe budgetary period from 2021 to 2027.

Funds

Fleury and Sabin combine to set up venture firm

CCCU establishes Emerging Ventures

Kuzmenkov sets up Perspective Ventures

Holtzbrinck helps HV Capital to $625m fund

Fountain Healthcare Partners finishes third fund

E14 Fund sparks bid for $80m successor

Exits

Ant Group, the Alibaba financial services spinoff that was set to go public on Thursday in a dual offering that would have been the largest flotation ever. I say was, because regulators have sensationally stepped in to suspend the offering due to concerns about Ant’s listing qualifications or disclosure requirements. For that to take place two days before an IPO is almost unheard of but for it to do so with a $34.3bn dual offering at a projected $313bn valuation seems momentous. It could be related to recent critical comments by chairman Jack Ma, but it’s also a big red flag to Chinese tech companies looking at Hong Kong or Shanghai’s Star Exchange as viable alternatives to the US markets.

China-based wealth management and peer-to-peer lending platform Lufax has floated on the New York Stock Exchange in one of the year’s largest initial public offerings, raising $2.36bn at a valuation just short of $33bn. Insurance group Ping An spun off Lufax and still owns a 39% stake, and the company’s other investors include Bank of China, Cofco, SBI, JP Morgan, UBS, Goldman Sachs, Macquarie Group and UOB. It had previously secured about $3bn across three rounds pre-IPO.

Speaking of on-demand services that have blossomed in recent months during the coronavirus pandemic, beverage delivery service Flaschenpost has seen its monthly sales zoom past $30m, across just 23 German cities, and has thus warranted a $1.16bn acquisition by packaged food producer Dr Oetker. The transaction will allow Vorwerk’s corporate venture capital arm, Vorwerk Ventures, to exit the company less than three years after taking part in a $24m round.

Freshly, the healthy meal kit service, has been acquired by Nestlé in a $950m deal that could stretch to $1.5bn once earnout payments have been taken into account. Nestlé led the company’s last round three years ago, when it raised $77m to take its total funding to $107m. Meal subscription services have come good during the coronavirus pandemic, and Freshly said it is now shipping a million meals a week in the US.

Ocado to pick up Kindred in $262m deal – Robotic picker provider Kindred Systems is set to be bought in a $262m cash transaction that will hand exits to Tencent and GV.

Intel integrates Stanford-backed SigOpt – Intel is set to buy Stanford University-backed machine learning optimisation business SigOpt, which had raised at least $8.6m in funding.

Merck & Co has agreed to pay $2.75bn in cash to acquire cancer drug developer VelosBio, handing exits to corporate venturing units Takeda Ventures and Chiesi Ventures. VelosBio had raised a touch over $200m prior to the acquisition, the brunt of which came in a Takeda-backed series B round in July. It also took part in Johnson & Johnson’s JLabs accelerator in early 2018.

Elsewhere in oncology, JW Therapeutics has scored a big exit for WuXi AppTec and Juno Therapeutics, the pharmaceutical companies that co-founded it four years ago, by floating in a $300m initial public offering in Hong Kong. They owned a combined stake sized at over 40% in JW pre-IPO having also participated in its $90m series A round in early 2018 and a $100m series B just three months ago.

TikTok owner ByteDance is among the most valuable VC-backed private companies in the world but its biggest rival in China, Kuaishou, isn’t far behind, and it looks like it’s going to be first to go public. Kuaishou has filed for an initial public offering on the Hong Kong Stock Exchange and recent reports suggested it would look to net up to $5bn at a valuation of about $50bn. The company’s backers include Tencent, which invested $2bn to lead its last round in late 2019, and Baidu.

Russian e-commerce platform Ozon has confirmed it has filed for an initial public offering on the Nasdaq Global Select Market that financial market sources told Reuters could generate up to $500m in proceeds. Sources told the Wall Street Journal last month the company would seek a $3bn to $5bn valuation in the IPO, and conglomerate Sistema, its largest shareholder, owns a stake sized above 45% once unconverted debt is taken into account.

Russian online streaming service Ivi has reportedly hired banks to organise an initial public offering slated to take place in the United States next year. The company’s investors include media company Prof-Media, which participated in a $40m round in 2012, as well as Baring Vostok, Tiger Global Management, Frontier Venture, RTP Global, Russian-Direct Investment Fund, Mubadala Investment Company, Flashpoint VC and Winter Capital.

Aeva is only three years old but the lidar-on-chip technology developer is set to list on the New York Stock Exchange through a reverse merger with special purpose acquisition company InterPrivate Acquisition Corp. The transaction will value the merged business at $2.1bn and it will benefit from $120m in PIPE financing from investors including carmaker Porsche, which had already invested a ‘significant’ amount in Aeva last December.

Upstart undertakes $100m filing – Rakuten, Alphabet and Progressive are in line for exits after the automated lending service filed to go public yesterday.

SQZ Bio squeezes on to NYSE – The AIG, Illumina, Alphabet and Orient Life-backed cell therapy developer priced its shares at the bottom of their range to raise $70.6m.

Deals

Reef Technology, 18 months ago it was ParkJockey, the owner of an app that allowed drivers to book parking spaces, but now, having rebranded to Reef Technology, it is focusing on converting underused space to hubs for on-demand services. It has also raised $700m from investors including SoftBank Vision Fund along with a $300m real estate fund. Given its target areas of cloud kitchens, on-demand healthcare, vertical farming and e-commerce logistics have all seen huge growth this year, you can see why.

CAR T-cell therapies are one of the fastest growing segments of the pharmaceutical space, and the latest cancer immunotherapy developer to close a sizeable round is Carsgen Therapeutics, which has bagged $186m in series C funding from investors including Lilly Asia Ventures. The round was led by private equity firm Loyal Valley Capital and the proceeds will support clinical trials for its oncology drug candidates in Asia, the US and Europe.

VIPThink pipes in $180m – New Oriental returned for the educational product developer’s series C round, which was led by SoftBank Vision Fund 2.

Digital signature technology provider eSign can perhaps be seen as China’s DocuSign, but it’s in an area where social distancing has necessarily led to increased use, and the company has raised $150m in series D funding. Its last round had been led by Ant Group, though the corporate (which let’s face it, has other things to deal with right now) was not listed as a participant in the latest round.

Conductor orchestrates $150m in funding – Viking Global led a $150m round for the Visa-backed banking software provider that will go to product development and international growth.

GetYourGuide discovers $133m – SoftBank Vision Fund returned in a convertible note round that pushed the total raised by the tourism experience booking service to some $788m.

Ronglian rings up $125m – New Oriental Industrial Fund helped Ronglian (aka Yuntongxun) close a series F round it claimed was the largest yet for a Chinese cloud communication technology producer.

Indonesian online marketplace Bukalapak has pulled in $100m from investors including Microsoft and Emtek at a valuation between $2.5bn and $3bn, according to Bloomberg. The company is reportedly targeting a total of $200m in the round, which comes after it closed an Emtek-backed series F round at a $2.5bn valuation in October.

University

ColdQuanta unpacks $32m series A – CU Boulder-founded quantum technology developer ColdQuanta has attracted series A funding to follow a $16.8m seed round closed two years ago.

Shoulder Innovations hoists up $21.6m – The series C funding will help Western Michigan portfolio company Shoulder Innovations build on the launch of its flagship shoulder replacement product.

Sense Bio pinpoints CIC for $50m round – Cambridge Innovation Capital has backed a round sized at up to $50m for disease testing kit producer Sense Biodetection, which has now raised more than $64m altogether.

“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0